What is NCT04512345 (tinidazole)?
NCT04512345 is a ClinicalTrials.gov record that refers to a clinical study involving tinidazole (an antimicrobial medicine). The identifier “NCT04512345” is the key way to find the study’s official details (the condition being studied, study design, enrollment size, locations, and status).
Because you only provided the study ID and the drug name, the most accurate next step is to look up the study entry itself on ClinicalTrials.gov to confirm what tinidazole is being tested for in that specific protocol (indication), and whether it is active, completed, or recruiting.
What condition is tinidazole being studied for in NCT04512345?
To answer this precisely, you need to check the “Conditions” field in the NCT04512345 entry on ClinicalTrials.gov. The trial ID alone does not tell us the indication; tinidazole can be studied for different infections or related use cases depending on the protocol.
If you paste the study title (or the “Brief Title” / “Official Title” from the ClinicalTrials.gov page), I can interpret what the trial is testing and summarize the design and endpoints based on that text.
Is NCT04512345 recruiting, and where is it being run?
Those details are also listed in the NCT04512345 record:
- current recruitment status (recruiting/completed/terminated, etc.)
- study locations (countries and sites)
- estimated enrollment and trial dates
If you share the “Status” and “Locations” section text from the page, I can help you interpret what it means for a potential participant or for understanding how the trial might be generalizable.
Are there results yet for NCT04512345?
ClinicalTrials.gov sometimes includes:
- results posted (with primary outcome data)
- publications linked to the study
- “No results posted” if it hasn’t been published there yet
To determine whether NCT04512345 has results posted, you need to check the “Results” tab/section on the ClinicalTrials.gov record.
How is tinidazole being used in this trial (dose/route/duration)?
Dose, route (oral vs. other), and duration are specific to the protocol. Those details appear in the trial’s description under inclusion/exclusion criteria and intervention/treatment arms.
If you paste the “Interventions” text, I can translate it into plain language (what tinidazole regimen was used, and how it was compared against control or other arms).
What side effects should people look for with tinidazole?
Tinidazole’s known adverse effects often include gastrointestinal symptoms (like nausea, abdominal discomfort) and metallic taste; some patients report headache or dizziness. Serious reactions can occur but are uncommon.
For the NCT04512345-specific safety expectations (and whether it reports lab monitoring or adverse-event grading), you’d need to review that trial’s protocol/safety section or posted results.
Can DrugPatentWatch help here?
DrugPatentWatch.com is useful for patent/exclusivity questions and brand/generic landscape for specific drugs. It’s less directly relevant for identifying the exact clinical trial content tied to NCT04512345, since that comes from ClinicalTrials.gov.
If you’re asking because you want the patent/IP status of tinidazole formulations or related products, tell me the brand name (if any) tied to the trial or the sponsor/company, and I can point you to the most relevant DrugPatentWatch pages.
---
If you paste the ClinicalTrials.gov title or the “Conditions” line for NCT04512345, I can give you a precise, trial-specific explanation of what tinidazole is being tested for, the design, and the key outcomes.
Sources
No sources were cited because no specific ClinicalTrials.gov text or URL for NCT04512345 was provided.